Conceptio › Archive › HAL (France)
HAL (France)open access

Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia

Benoit Demuynck et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
Hypochondroplasia, Achondroplasia, 0, Skeletal dysplasia, Infigratinib, FGF receptor 3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 670227
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.